Dornase Alfa Uses, Dosage, Side Effects and Interactions
Pulmozyme
Pulmozyme is a brand of dornase alfa that comes as an inhalation solution (nebulizer).
Dornase alfa is an inhaled enzyme medicine used with standard therapies to help people with cystic fibrosis breathe better.
Quick links
Ask Anything About Dornase AlfaType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Dornase Alfa in Short
- Drug class Recombinant Human Deoxyribonuclease 1 How the FDA classifies it
What it treatsDornase alfa, sold as Pulmozyme, is used along with standard therapies to manage cystic fibrosis (CF) in children and adults. Its goal is to improve lung function. In people with CF whose FVC (a lung function measure) is 40% of predicted or higher, daily use has also been shown to lower the risk of respiratory tract…
- How you get it Prescription only
- Comes asInhalation solution (nebulizer) (inhaled)
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- What pharmacies pay
- Pulmozyme (brand)$53.22 per mL of the inhaler’s contents
The Pharmacist’s Take
Dornase alfa (Pulmozyme) is an inhaled enzyme that cuts up the DNA from broken-down white blood cells that makes cystic fibrosis mucus thick and sticky, helping the airways clear and lung function improve; used with standard CF treatments in children and adults, it has been a mainstay of daily CF care since about 1993 and is still available only as the brand. Most people tolerate it well; a hoarse or changed voice and a sore throat are what they notice most. Get medical help for a rash, swelling or trouble breathing (possible signs of an allergic reaction), or for chest pain or worsening shortness of breath.
Key Takeaways From the HelloPharmacist Team
- Inhale it through a nebulizer once a day, or twice a day if prescribed, and use only a nebulizer type recommended for Pulmozyme.
- Run it as its own treatment, never mixed or diluted with your other nebulizer medicines, since mixing can change how either drug works.
- Keep up your airway clearance and other CF treatments, because this medicine works alongside them rather than replacing them.
- Squeeze each ampule to check for leaks, skip any that looks cloudy or discolored, and use or discard the whole ampule once opened.
Patient Information Guide for Dornase Alfa
What It’s Used For
Dornase alfa is used for cystic fibrosis. These uses apply to Pulmozyme inhalation solution:
- Pulmozyme is used with standard therapies to improve lung function in children and adults with cystic fibrosis (CF).
- In CF patients with an FVC of 40% of predicted or higher, daily Pulmozyme has also been shown to reduce the risk of respiratory tract infections needing antibiotics by injection or IV.
How It Works
Dornase alfa is a lab-made version of a human enzyme called DNase I. It cuts up DNA. In CF, thick infected mucus holds a lot of DNA from broken-down white blood cells.
In lab studies, dornase alfa broke down this DNA in CF sputum and made it less thick and sticky. Thick mucus in the airways contributes to poorer lung function and infection flare-ups.
Drug Class
Drug Class
- Recombinant Human Deoxyribonuclease 1
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Recombinant Human Deoxyribonuclease 1
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)None listed for Dornase Alfa in the FDA’s index.
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)- Decreased Respiratory Secretion Viscosity
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Deoxyribonuclease I
- Recombinant Proteins
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Mucolytics
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Pulmozyme is inhaled through a nebulizer, usually once a day. Some people may benefit from twice daily use.
Follow your prescriber's directions.
- Use a recommended jet nebulizer with an air compressor, or a recommended vibrating mesh nebulizer.
- The eRapid system is only for people who can use a mouthpiece, not those who need a mask.
- Squeeze each ampule to check for leaks. Do not use cloudy or discolored solution.
- Use or discard the entire ampule once opened.
- Do not dilute it or mix it with other drugs in the nebulizer.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Cystic fibrosis lung function
Cystic fibrosis, patients who may benefit from twice daily administration Usual dose 2.5 mg (one single-dose ampule) inhaled twice a day
Good to know
Some patients may benefit from twice daily administration
Children and adults with cystic fibrosis Usual dose 2.5 mg (one single-dose ampule) inhaled once a day
- 2.5 mg (one single-dose ampule) inhaled once daily using a recommended jet nebulizer connected to an air compressor system or via a vibrating mesh nebulizer
Side Effects
In clinical trials in people with CF, these were more common with Pulmozyme than with placebo:
Common side effects
- Voice changes
- Sore throat (pharyngitis)
- Rash
- Laryngitis (hoarse, irritated voice box)
- Chest pain
- Red, irritated eyes (conjunctivitis)
- Runny or stuffy nose (rhinitis)
- Fever
- A drop in FVC of 10% or more
When to get medical help
- Call your doctor if you have a rash, swelling or trouble breathing that could signal an allergic reaction.
- Get medical help for chest pain or worsening shortness of breath.
- Tell your care team if side effects are bothersome or do not go away.
Most reactions were mild and short-lived, and few people had to stop treatment. Report side effects to your doctor, Genentech at 1-888-835-2555, or FDA MedWatch.
Warnings and Precautions
The label lists no specific warnings or precautions. The key safety point is not to use it if you are allergic to it.
- Use only recommended nebulizers.
- Never mix it with other drugs in the nebulizer.
Interactions
The label says there are no clinically important drug-drug interactions.
- Do not mix Pulmozyme with other drugs in the nebulizer. Mixing could change how Pulmozyme or the other drug works.
Interactions Listed in the FDA-Approved Label
From the Dornase Alfa prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Other drugs (drug-drug interactions)What happensAvailable data indicate there are no clinically important drug-drug interactions with PULMOZYME.
-
Other drugs mixed in the nebulizerWhat happensMixing PULMOZYME with other drugs could lead to adverse physicochemical and/or functional changes in PULMOZYME or the admixed compound.What to doDo not dilute or mix PULMOZYME with other drugs in the nebulizer.
Read the label’s full interactions text
7 DRUG INTERACTIONS Available data indicate there are no clinically important drug-drug interactions with PULMOZYME.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use it if you are allergic to dornase alfa, Chinese Hamster Ovary cell products, or any ingredient in it.
- Pregnancy: no adequate studies in pregnant women. Animal studies showed no fetal harm.
- Breastfeeding: not known if it is in human milk. Discuss benefits and risks with your doctor.
- Children: safety and effectiveness have been established in pediatric CF patients, including use supported in those under 5 years.
- Older adults: too few people 65 and older were studied to know if they respond differently.
Half-Life and How Your Body Processes It
After inhalation, dornase alfa is measurable in sputum within 15 minutes. Levels fall by about two hours later. Inhaling it did not significantly raise blood levels above normal natural levels, and it did not build up in the blood with repeated use.
It is expected to be broken down by proteases (enzymes that digest proteins) in body fluids. An IV study suggested a half-life of 3 to 4 hours.
Storage
Store PULMOZYME ampules at a refrigerated temperature between 2°C to 8°C (36°F to 46°F) in their protective foil to protect from light and heat. Refrigerated in the protective foil pouch to protect from light and heat.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Dornase Alfa: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Dornase Alfa — the kind of thing our pharmacy team would talk through with you at the counter.
What is Pulmozyme (dornase alfa) used for?
How do I use Pulmozyme?
Can I mix Pulmozyme with my other nebulizer medicines?
What side effects should I expect?
Is Pulmozyme safe during pregnancy or breastfeeding?
Can children use Pulmozyme?
Is dornase alfa available over the counter?
When was dornase alfa first available?
What is the brand name of dornase alfa?
What is the generic name of Pulmozyme?
What drug class is dornase alfa?
What strengths does dornase alfa come in?
How much does dornase alfa cost?
Is there a dornase alfa shortage?
Where can I read the dornase alfa prescribing information (package insert)?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Dornase Alfa
Skip the scrolling. Ask in your own words and get an answer from Dornase Alfa’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Dornase Alfa’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Dornase Alfa on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Dornase Alfa Forms and Strengths (How It Comes)
Dornase Alfa comes in 1 dose form, the inhalation solution (nebulizer). Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Dornase Alfa inactive ingredients by manufacturer.
Inhalation solution (nebulizer)
How this form is used
- Pulmozyme is used with standard therapies to improve lung function in children and adults with cystic fibrosis.
- Pulmozyme daily use has been shown to reduce the risk of respiratory infections needing injected antibiotics in CF patients with an FVC of 40% of predicted or higher.
- Pulmozyme is inhaled once daily in most people, and some may benefit from twice daily use.
- Pulmozyme should be used with a recommended jet nebulizer with an air compressor or a recommended vibrating mesh nebulizer.
- Pulmozyme ampules should be squeezed to check for leaks, and discarded if the solution is cloudy or discolored.
- Do not dilute Pulmozyme or mix it with other drugs in the nebulizer.
Dornase Alfa on the U.S. Market: Products, Makers and Brands
How Dornase Alfa appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
1 company lists 1 Dornase Alfa product record with the FDA, mostly as inhalation solution (nebulizer); the earliest marketing or approval year on record is 1993. The one brand name in the directory today is Pulmozyme; the rest are generics.
Also listed with the FDA, not a patient dose form: Unfinished liquid (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
How Widely Dornase Alfa Is Used (Medicaid Data)
How many Dornase Alfa prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Dornase Alfa prescribed? Of the 1,682 medications we measure, Dornase Alfa ranks #675 by Medicaid prescriptions — more than 60% of them.
Utilization by Dornase Alfa product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
dornase alfa 1 MG/ML Inhalation Solution
1 of 2 listed NDCs had Medicaid claims. RxNorm 310014
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 1 of the 2 listed Dornase Alfa NDCs had Medicaid claims.
Compare Dornase Alfa Products
A representative set of FDA-listed product records for Dornase Alfa — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Inhalation solution (nebulizer) | ||||
| 1 mg/mL | Respiratory (inhalation) | Genentech, Inc. | BLA | View NDC → |
Showing 1 of 1 products — FDA National Drug Code Directory. See every product, package size and price: browse all 1 Dornase Alfa NDCs →
Dornase Alfa Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Dornase Alfa — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Dornase Alfa in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Dornase Alfa FDA Approval History
How Dornase Alfa went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Dornase Alfa Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Dornase Alfa recalls since July 2021.
✅No Dornase Alfa recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Dornase Alfa in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 1
- Strengths
- 1
- Forms in current FDA listings
- 1 of 1
RxCUI 337623 -
Dose form (SCDF) Inhalation SolutionIn current FDA listings
RxCUI 2108354Its strength (SCD)-
1 mg/mL
RxCUI 310014
-
1 mg/mL
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Dornase Alfa Supply and Shortage Status
Whether Dornase Alfa is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Dornase Alfa Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Dornase Alfa: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a strength to see how its price has changed since Nov 2023.
For brand-name Pulmozyme, the 1 mg/mL inhalation solution (nebulizer), pharmacies paid an average of $53.22 per mL as of Nov 18, 2026, up 3% from $51.66 a year earlier.
- What pharmacies pay now
- $53.22
- per mL, as of Nov 18, 2026
- Last 4 weeks
- No change
- from $53.22 on Oct 21, 2026
- Last 12 months
- Up 3%
- from $51.66 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $49.02 to $53.25
- per mL
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $53.22 |
| Oct 2026 | $53.22 |
| Sep 2026 | $53.16 |
| Aug 2026 | $53.08 |
| Jul 2026 | $53.06 |
| Jun 2026 | $53.12 |
| May 2026 | $53.18 |
| Apr 2026 | $53.25 |
| Mar 2026 | $53.25 |
| Feb 2026 | $53.25 |
| Jan 2026 | $53.25 |
| Dec 2025 | $51.70 |
| Nov 2025 | $51.66 |
| Oct 2025 | $51.62 |
| Sep 2025 | $51.57 |
| Aug 2025 | $51.56 |
| Jul 2025 | $51.54 |
| Jun 2025 | $51.49 |
| May 2025 | $51.37 |
| Apr 2025 | $51.66 |
| Mar 2025 | $51.66 |
| Feb 2025 | $51.66 |
| Jan 2025 | $51.66 |
| Dec 2024 | $50.16 |
| Nov 2024 | $50.24 |
| Oct 2024 | $50.27 |
| Sep 2024 | $50.23 |
| Aug 2024 | $50.29 |
| Jul 2024 | $50.28 |
| Jun 2024 | $50.26 |
| May 2024 | $50.23 |
| Apr 2024 | $50.49 |
| Mar 2024 | $50.49 |
| Feb 2024 | $50.49 |
| Jan 2024 | $50.49 |
| Dec 2023 | $49.02 |
| Nov 2023 | $49.02 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Inhalation solution (nebulizer) · Respiratory (inhalation) | 1 mg/mL | Pulmozyme (brand) | $53.22 per mL | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Dornase Alfa Brand Names
Dornase Alfa has one brand name on record: Pulmozyme. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Dornase Alfa: Manufacturers and Labelers
One company lists Dornase Alfa products with the FDA. By number of product records, the largest are Genentech, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Dornase Alfa Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Genentech, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →